<p>Table showing 14 inhibitors tested in combination with ZKN-157. Combination effects were color coded blue (synergism) or orange (antagonism) according to the scores obtained from the BI analysis</p>
<p>ZKN-157 selectively inhibits new protein synthesis in a sensitive colorectal cancer cell line. <b>A,</b> Volcano plot showing heavy-isotope intensities (newly synthesized protein abundance) for 2867 proteins detected at 24-hour timepoint. Protein were classified as follows: Decreased (log<sub>2</sub>FC < −0.4, <i>P</i><sub>adjusted</sub> < 0.05, red), Downward Trend (log<sub>2</sub>FC < −0.4, <i>P</i><sub>adjusted</sub> > 0.05, pink), Increased (log<sub>2</sub>FC > 0.4, <i>P</i><sub>adjusted</sub> < 0.05, dark green), Upward Trend (log<sub>2</sub>FC > 0.4, <i>P</i><sub>adjusted</sub> > 0.05, light green), Unchanged (−0.4 < log<sub>2</sub>FC < 0.4, <i>P</i><sub>adjusted</sub> > 0.05, dark gray). Dotted lines indicate −0.5 and 0.5 log<sub>2</sub>FC values. <b>B,</b> Bar graph plotting percent protein fraction of heavy-isotope intensity (categorized as in <b>A</b>) at 24-hour timepoint versus positively charged regions. Positive charge windows were generated by assigning K and R residues a positive 1 charge and all other amino acid residues a charge of 0. Average charge values were then calculated along a 10-amino acid long sliding window for each protein's amino acid sequence (starting at the first residue and ending at the last complete set of 10 residues). <b>C,</b> Overrepresentation analysis and pathway enrichment in significantly downregulated proteins from <b>A</b> are shown. Count refers to the number of genes found in each pathway while gene ratio refers to the count divided by all genes in the pathway. <b>D,</b> Bar graph showing nascent protein abundance for 68 Ribosomal proteins from heavy-isotope intensity analysis at 24-hour timepoint (categorized as in <b>A</b>). The dotted line indicates −0.4 log<sub>2</sub>FC value.</p>
<p>ZKN-157 selectively inhibits new protein synthesis in a sensitive colorectal cancer cell line. <b>A,</b> Volcano plot showing heavy-isotope intensities (newly synthesized protein abundance) for 2867 proteins detected at 24-hour timepoint. Protein were classified as follows: Decreased (log<sub>2</sub>FC < −0.4, <i>P</i><sub>adjusted</sub> < 0.05, red), Downward Trend (log<sub>2</sub>FC < −0.4, <i>P</i><sub>adjusted</sub> > 0.05, pink), Increased (log<sub>2</sub>FC > 0.4, <i>P</i><sub>adjusted</sub> < 0.05, dark green), Upward Trend (log<sub>2</sub>FC > 0.4, <i>P</i><sub>adjusted</sub> > 0.05, light green), Unchanged (−0.4 < log<sub>2</sub>FC < 0.4, <i>P</i><sub>adjusted</sub> > 0.05, dark gray). Dotted lines indicate −0.5 and 0.5 log<sub>2</sub>FC values. <b>B,</b> Bar graph plotting percent protein fraction of heavy-isotope intensity (categorized as in <b>A</b>) at 24-hour timepoint versus positively charged regions. Positive charge windows were generated by assigning K and R residues a positive 1 charge and all other amino acid residues a charge of 0. Average charge values were then calculated along a 10-amino acid long sliding window for each protein's amino acid sequence (starting at the first residue and ending at the last complete set of 10 residues). <b>C,</b> Overrepresentation analysis and pathway enrichment in significantly downregulated proteins from <b>A</b> are shown. Count refers to the number of genes found in each pathway while gene ratio refers to the count divided by all genes in the pathway. <b>D,</b> Bar graph showing nascent protein abundance for 68 Ribosomal proteins from heavy-isotope intensity analysis at 24-hour timepoint (categorized as in <b>A</b>). The dotted line indicates −0.4 log<sub>2</sub>FC value.</p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.